We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Clinical study shows uninterrupted trimethoprim-sulfamethoxazole does not delay engraftment in stem cell recipients, suggesting continuous prophylaxis is safe.
No takes yet. Share an insight, caveat, or question.
Färber et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: